JAK drugs for Psoriatic Arthritis
2 tracked JAK drugs in the Psoriatic Arthritis race. The class explanation lives on the JAK page; the full indication pipeline across every mechanism is on the Psoriatic Arthritis page.
2 approved / phase 4
Head-to-head evidence: tofacitinib vs upadacitinib